Ticagrelor API
Lewens Labs develops and manufactures Ticagrelor API — P2Y12 platelet aggregation inhibitor, a reversibly-binding oral antiplatelet used after acute coronary events — used in the treatment of acute coronary syndrome, at its GMP facility in Gujarat, India.
Note for Lewens: populate CAS, formula, grade, DMF/CEP & registrations for Ticagrelor from the Regulatory master list.
Why Ticagrelor rewards process depth.
Ticagrelor involves cyclopropylamine and triazolopyrimidine chemistry with demanding chiral control.
Lewens' integrated platform — process R&D, analytical development and manufacturing under one team — is built for exactly this kind of technically demanding molecule. We can support Ticagrelor as commercial supply, as a second source, or as a development and custom-synthesis programme through our CDMO platform.
Three ways to source Ticagrelor.
Ongoing supply
Reliable, on-specification commercial quantities of Ticagrelor API for your registered product.
Alternate supplier
De-risk your supply chain for Ticagrelor with a dependable additional or backup source.
Custom & CDMO
Process development, improvement or exclusive arrangements for Ticagrelor under NDA.
More in Cardiovascular.
Ticagrelor API — FAQs.
Does Lewens manufacture Ticagrelor API?
Can Lewens supply Ticagrelor as a second source?
What is Ticagrelor used for?
Need Ticagrelor API?
Request specifications, samples or DMF/CEP documentation — or discuss a second-source or custom-synthesis programme.